Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint

Share Article

Bernstein Liebhard LLP is currently representing plaintiffs who have testosterone treatment lawsuits pending in the federal multidistrict litigation. The Defendants' answers detail defenses to allegations raised by plaintiffs, including those represented by the Firm.

Free Case Review
We are pleased that this proceeding continues to progress in an efficient manner, as our Firm is representing a number of plaintiffs who have cases pending in the federal testosterone litigation.

Hundreds of testosterone treatment lawsuits (http://www.testosteronelawsuithub.com/) filed on behalf of men who allegedly suffered serious cardiovascular complications due to their use of prescription testosterone replacement therapies continue to move forward in the federal multidistrict litigation underway in U.S. District Court, Northern District of Illinois. According to court documents dated May 1st, defendants AbbVie, Inc., Auxilium Pharmaceuticals, Inc., Actavis, Inc. Endo Pharmaceuticals, and GlaxoSmithKline have submitted their answers to the plaintiffs’ Master Long Form Complaint. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“The Master Long Form Complaint set forth all of the common allegations of fact being pursued by testosterone lawsuit plaintiffs, while the answers submitted by AbbVie and other pharmaceutical companies detail, among other things, the defenses to those claims. We are pleased that this proceeding continues to progress in an efficient manner, as our Firm is representing a number of plaintiffs who have cases pending in the federal testosterone litigation,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free case reviews to men who allegedly experienced heart attacks, strokes and dangerous cardiovascular side effects due to low testosterone treatments.

Testosterone Litigation
Court records indicate that just under 1,400 testosterone lawsuits are currently pending n the Northern District of Illinois against the manufacturers of testosterone replacement medications. All of the complaints were filed on behalf of men who allegedly experienced heart attacks, strokes and other life-threatening cardiovascular events due their use of the drugs. Among other things, the various defendants have been accused of failing to adequately warn patients of these risks, and of wrongly marketing their testosterone therapies as appropriate treatments for low libido, muscle loss, fatigue and other symptoms commonly associated with male aging.

According to court documents, the federal testosterone litigation underway in the Northern District of Illinois was established by the U.S. Judicial Panel on Multidistrict Litigation (JPML) in June 2014. The Panel’s June 6th Order noted that all of the actions had been filed in the wake of the U.S. Food & Drug Administration’s (FDA) January 31, 2014 announcement that it was reviewing the cardiovascular risks allegedly associated with testosterone therapy.* According to Bernstein Liebhard LLP, on March 3, 2015, the FDA ordered the manufacturers of prescription testosterone treatments to add new information to the drug’s labels regarding a potential association with heart attack and stroke. The agency also mandated that language pertaining to their approved indications be modified to clearly state that testosterone therapy has not been proven safe and effective for relieving symptoms associated with age-related drops in testosterone.

Men who allegedly suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism or other serious cardiovascular events due to their use of low testosterone therapy may be eligible for compensation for medical bills, lost wages and other injury-related damages. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*fda.gov/Drugs/DrugSafety/ucm383904.htm, FDA, January 31, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sandy A. Liebhard
Follow us on
Visit website